Top Markets
#1 DogBull DogBull +54.73%
#2 Siren Siren +31.33%
#3 OriginTrail OriginTrail +17.13%
#4 龙虾 (Lobster) 龙虾 (Lobster) +9.48%
#5 Yield Basis Yield Basis +9.42%
#6 Verus Coin Verus Coin +7.40%
#7 Stargate Finance Stargate Finance +7.16%
#8 Collect on Fanable Collect on Fanable +6.91%
#9 LayerZero LayerZero +6.90%
#10 COTI COTI +6.55%
Coin of the day
DogBull DogBull
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Asensus Surgical, Inc. Asensus Surgical, Inc.

Asensus Surgical, Inc.

ASXC
Classifica tra le azioni #22069
Asensus Surgical, Inc., a medical technology enterprise established in 2006 and... Asensus Surgical, Inc., a medical technology enterprise established in 2006 and headquartered in Durham, North Carolina, focuses on the research, development, and commercialization of robotic medical devices. Its core mission is to elevate minimally invasive surgical procedures throughout the United States, Europe, and Asia through innovative robotic solutions. The company's unique approach involves digitally bridging the gap between surgeons and patients, thereby introducing a new paradigm of "Performance-Guided surgery." This system aims to equip surgeons with critical clinical intelligence, ensuring consistently superior patient outcomes and setting a higher benchmark for surgical standards. Key products include the Senhance Surgical system, a multi-port robotic platform that can maneuver up to four arms to precisely control surgical instruments and a camera during laparoscopic operations. Their product line also features a range of specialized instruments, such as 3mm diameter instruments, 3mm and 5mm hooks, and articulating tools. Additionally, they offer the Senhance ultrasonic system, an advanced energy device designed for accurate, controlled tissue ligation and division. The company, initially known as TransEnterix, Inc., officially rebranded to Asensus Surgical, Inc. in February 2021.
Prezzo delle azioni
$0.3479
Ultima sincronizzazione: 2024-08-21
Capitalizzazione di mercato
$94.92M
Variazione (1 giorno)
0.64%
Variazione (1 anno)
0.00%
Paese
US
Scambia Asensus Surgical, Inc. (ASXC)

Categoria

Healthcare
Margine operativo per Asensus Surgical, Inc. (ASXC)
Margine operativo al August 2026 TTM: -926.52%
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Asensus Surgical, Inc., il margine operativo attuale (TTM) è -926.52%. Alla fine del 2022, il margine operativo era -1,067.86%.
Storico del margine operativo per Asensus Surgical, Inc. da 2000 a 2026
Margine operativo alla fine di ogni anno
Anno Margine Operativo Cambia
2026 (TTM) -926.52% 0.00%
2023 -926.52% -13.24%
2022 -1,067.86% 36.04%
2021 -784.97% -58.73%
2020 -1,902.02% 4.97%
2019 -1,811.92% 788.50%
2018 -203.93% -76.58%
2017 -870.86% -89.30%
2016 -8,140.16% 0.00%
2015 0.00% -100.00%
2014 -9,129.43% 410.24%
2013 -1,789.24% 468.63%
2012 -314.66% 0.00%
2011 0.00% -100.00%
2010 18,431.03% 0.00%
2009 0.00% 0.00%
2008 0.00% -100.00%
2007 2,052.59% 0.00%
2006 0.00% 0.00%
2005 0.00% 0.00%
2004 0.00% -100.00%
2003 -462.77% 1,370.04%
2002 -31.48% 842.51%
2001 -3.34% -265.35%
2000 2.02% 0.00%
Margine operativo per aziende simili o concorrenti
Azienda Margine Operativo Differenza del margine operativo Il paese
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
17.03% -100.02%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
22.03% -100.02%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
17.86% -100.02%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
21.46% -100.02%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
0.00% -
DE
Cos'è l'Margine operativo di un'azienda?
L'Margine operativo è un indicatore chiave per valutare la redditività di un'azienda. Margini operativi più elevati sono generalmente preferibili poiché indicano che l'azienda riesce a vendere i propri prodotti o servizi a un prezzo significativamente superiore rispetto ai costi di produzione. Si calcola dividendo gli utili per i ricavi.